Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Carisma Therapeutics ( (CARM) ) just unveiled an update.
Michael Torok is stepping down from Carisma Therapeutics’ board of directors due to other professional commitments, making way for the appointment of Sohanya Cheng. Cheng will join the audit committee and receive a compensation package including cash and stock options, aligning with the company’s non-employee director compensation policy. Her appointment reflects a seamless transition in leadership, offering stability and continuity for the company’s governance.
For detailed information about CARM stock, go to TipRanks’ Stock Analysis page.